Skip to main content
Home
  • Get Care
    • Find a Doctor
    • Request an Appointment
    • Virtual Visits
    • Locations & Directions
    • News
    • About Columbia Surgery
    • All Resources
  • Surgical Specialties
      • Adrenal
      • Aorta
      • Breast
      • Colorectal
      • Colorectal (Global Center)
      • Esophageal
      • Gall Bladder & Appendix
      • Gastric Cancer
      • Heart (Adult)
      • Heart (Pediatric)
      • Hernia
      • Kidney/Pancreas Transplantation
      • Liver Transplantation
      • Lung & Chest
      • Melanoma
      • Pancreas
      • Parathyroid
      • Pediatric/Neonatal
      • Plastic & Reconstructive
      • Robotic Surgery
      • Sarcoma
      • Thyroid
      • Vascular
      • Weight Loss Surgery
    • All Specialties
  • Research & Trials
    • About Research
    • About Clinical Trials
    • Basic & Translational Research
    • Cardiovascular Research
    • Clinical Research
    • Innovation & Outcomes Research
    • Translational Immunology Research
    • Transplant Research
    • All Research & Trials
  • Conditions & Treatments
      • Adrenal
      • Aortic
      • Breast
      • Colorectal
      • Esophageal
      • Gallbladder & Appendix (General Surgery)
      • Heart (Adult)
      • Hernia
      • Kidney
      • Liver
      • Lung & Chest (Thoracic)
      • Pancreas
      • Parathyroid
      • Pediatric (Neonatal)
      • Plastics (Cosmetic & Reconstructive)
      • Skin
      • Stomach (Gastric)
      • Thyroid
      • Vascular
      • Weight Loss (Bariatric)
    • All Conditions and Treatments
  • For Students and Professionals
  • Ways to Help
  • Request an Appointment

Search results

A Phase Ib/II, multicenter, open label, study of LEE011 in combination with MEK162 in adult patients with NRAS mutant melanoma

… The purpose of this protocol is to evaluate the effects of the combination of two drugs, LEE011 and … A Phase Ib/II, multicenter, open label, study of LEE011 in combination with MEK162 in adult patients with …

Last Modified: 02/13/2023 - 21:06

A Phase III Randomized, Controlled, Superiority Study Evaluating EVARREST Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During Hepatic Surgery

… To evaluate the safety and hemostatic effectiveness of EVARREST™ Fibrin Sealant Patch (EVARREST) versus standard of care treatment (SoC) in controlling parenchymal bleeding … Evaluating EVARREST Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During …

Last Modified: 02/13/2023 - 21:06

Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone In Patients With Incurable Lung or Non- Colorectal Gastrointestinal Malignancies

… To determine the efficacy of early integrated palliative care on patient reported quality of life at 12 weeks using the FACT in patients with … Randomized Study of Early Palliative Care Integrated With Standard Oncology …

Last Modified: 02/13/2023 - 21:07

A Phase II Randomized Multicenter Placebo- Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant (OLT) Recipients with Hepatocellular Carcinoma (HCC)

… The purpose of this study is to determine if sorafenib (sorafenib tosylate) is a safe … for liver cancer patients, but despite transplantation, the liver cancer can recur in the new, transplanted liver. It … Randomized Multicenter Placebo- Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver …

Last Modified: 02/13/2023 - 21:06

Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052) (C-SURFER)

… A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects … pharmacokinetic sampling. The primary study hypothesis is that the proportion of participants achieving a sustained … Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants …

Last Modified: 02/13/2023 - 21:06

A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection

… This Registry is designed to obtain long term data on participants who have … A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response …

Last Modified: 02/13/2023 - 21:06

A Phase 3b study to evaluate the long-term outcomes following treatment with Abbvie DAAs and with or without Ribavirin (RBV) in adults with genotype 1 Chronic Hepatitis C Virus (HCV) Infection

… The purpose of this study is to evaluate Long-term Outcomes following treatment with … A Phase 3b study to evaluate the long-term outcomes following treatment with Abbvie DAAs …

Last Modified: 02/13/2023 - 21:06

Prospective Randomized Double Blind Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent Recurrent Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C Virus Infection

… The purpose of this study is to determine if the administration of a poorly-absorbable antibiotic … Randomized Double Blind Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent …

Last Modified: 02/13/2023 - 21:06

An Expanded Access Phase 2 Study of Sofosbuvir with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver Transplantation and Who Have Aggressive, Recurrent Hepatitis C infection

… This is a single arm, open-label study which will be opened at specific clinical sites at the request of an investigator for the treatment of individual subjects … An Expanded Access Phase 2 Study of Sofosbuvir with Ribavirin and with or without Pegylated …

Last Modified: 02/13/2023 - 21:06

A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenoca

… The purpose of this study is to compare the efficacy and safety of PEGPH20 combined with … A Study of PEGylated Recombinant Human Hyaluronidase in Combination …

Last Modified: 02/13/2023 - 21:07

A 24-month, multi-center, single arm, prospective study to evaluate renal function, efficacy, safety and tolerability of everolimus in combination with reduced exposure cyclosporine or tacrolimus in paediatric liver transplant : CRAD001H2305

… This study is designed to assess the evolution of renal function and to … evaluate renal function, efficacy, safety and tolerability of everolimus in combination with reduced exposure …

Last Modified: 02/13/2023 - 21:06

PRO 02/ML28897 MY PATHWAY STUDY: An Open-Label Phase IIA Study Evaluating Trastuzumab/ Pertuzumab, Erlotinib, Vermurafenib, and Vismodegib in Patients Who Have Advanced Solid Tumors with Mutations or Gene Expression Abnormalities Predictive of Response to

… regimens will be evaluated simultaneously in groups of patients who have advanced solid tumors that has … are not available, and in whom a trial of targeted therapy is considered the best available treatment option. Erlotinib is a targeted … with Mutations or Gene Expression Abnormalities Predictive of Response to …

Last Modified: 02/13/2023 - 21:06

World’s Most Comprehensive Care for IBD

… Columbia’s Division of Colorectal Surgery has unmatched expertise in the surgical management of Crohn’s Disease and ulcerative … latest techniques to improve the patient’s condition and quality of life.” The Columbia team is often able to conserve …

Last Modified: 03/03/2026 - 11:37

Pediatric Heart Valve Center

… The Pediatric Heart Valve Center at Columbia is dedicated to improving the quality of care for children and adults with congenital heart valve …

Last Modified: 01/21/2026 - 18:33

Our Breast Programs & Services

… As a major academic facility, we stand at the forefront of medical care, patient services, and health research. We … Program for Breast Centers (NAPBC) for the high-quality care we deliver. Learn about the NAPCB center . To …

Last Modified: 09/17/2025 - 13:20

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • ›› Next page
  • Last » Last page

Footer About

  • About Us
  • Request an Appointment
  • Virtual Visits
  • Organ Donation
  • Contact Us
  • Subscribe To Our Newsletter

Footer About 2

  • Directory
  • Alumni/JJSS
  • Locations & Directions
  • Ways to Help
  • Disclaimer
FOLLOW US
  • Twitter Logo
  • Facebook Logo
  • Youtube Logo
  • Instagram Logo
Visit
  • New York Presbyterian Logo
  • Columbia University Irving Medical Center Logo

©1999-2026. Columbia University Irving Medical Center, Department of Surgery, New York, NY.